SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 192.97-1.6%Jan 16 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Night Trader who wrote (12927)1/1/1998 4:31:00 PM
From: Henry Niman  Read Replies (1) of 32384
 
martin, I have a Zack's report dated 12/13/97 which shows the following for LGND:
FISC YR END 12/98 -0.87 -0.51 -1.25 4 0.00
FISC YR END 12/97 -1.35 -1.17 -1.59 5 -0.01
For the past year there are 5 estimates ranging from a loss of 1.17 to a loss of 1.59 with an average of 1.35. Since they were 5 brokerage houses covering LGND, I assume that each made an estimate for the year.

With Raymond James on the sidelines, there are 4 houses covering LGND and Zacks shows 4 estimates (which would be before the Bear Stearns revision of 12/31/97) for 1998. They show a rather dramatic improvement, with losses ranging from 0.51 to 1.25 with an average loss of just 0.87 for the year. I expect those numbers to be even lower after Bear Stearns' lastest numbers are factored in. Although the range in estimates is quite large, the trend is very clear. A loss of 51 cents for the year is less than $20 million, which strongly suggests that there will be no secondary. Even the worst case scenario of a loss of 1.25 would leave LGND with a significant amount of cash in the bank at the end of 1998, and I suspect that most analysts will be predicting a profit sometime between the end of this year and the end of next year.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext